Trial Profile
Assessment of the effects of sugammadex on coagulation profiles using thromboelastographic parameters
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2018
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Adverse reactions
- 08 Jan 2018 Status changed from recruiting to completed.
- 17 Nov 2016 New trial record